CPRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,988,983.30

Catalyst Pharmaceuticals Insider Trading History Chart

Catalyst Pharmaceuticals Share Price & Price History

^$23.40

▼ -0.25 (-1.06%)

As of 05/14/2025 05:00 PM ET

Days: 30 | 90 | 365

Catalyst Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2025	Gary Ingenito	Insider	Sell	44,904	$22.09	$991,929.36	68,873
3/3/2025	Brian Elsbernd	Insider	Sell	62,975	$22.98	$1,447,165.50	188,564
12/10/2024	Steve Miller	Insider	Sell	50,000	$21.93	$1,096,500.00	686,996
11/27/2024	Gary Ingenito	Insider	Sell	12,000	$22.72	$272,640.00	51,391
11/27/2024	Molly Harper	Director	Sell	17,500	$22.00	$385,000.00
8/21/2024	David S. Tierney	Director	Sell	15,000	$20.10	$301,500.00	348,874
8/20/2024	Steve Miller	Insider	Sell	150,000	$20.35	$3,052,500.00	675,124
8/9/2024	Jeffrey Del Carmen	Insider	Sell	36,058	$18.42	$664,188.36	12,369
6/7/2024	Jeffrey Del Carmen	Insider	Sell	7,541	$16.07	$121,183.87	18,427
6/5/2024	Gary Ingenito	Insider	Sell	80,000	$16.16	$1,292,800.00	51,391
6/4/2024	Richard J. Daly	CEO	Sell	17,323	$15.97	$276,648.31	234,824
6/3/2024	Molly Harper	Director	Sell	5,333	$16.30	$86,927.90
4/8/2024	David S. Tierney	Director	Sell	25,000	$15.68	$392,000.00	348,874
3/27/2024	Brian Elsbernd	Insider	Sell	25,000	$16.44	$411,000.00	124,433
12/12/2023	David S. Tierney	Director	Sell	50,000	$13.32	$666,000.00	333,541
12/11/2023	Alicia Grande	CFO	Sell	60,000	$13.76	$825,600.00	50,557
12/8/2023	Alicia Grande	CFO	Sell	40,000	$14.28	$571,200.00	50,557
12/5/2023	Steve Miller	Insider	Sell	40,000	$14.24	$569,600.00	647,457
5/15/2023	Patrick J. McEnany	CEO	Sell	26,151	$13.23	$345,977.73	3,945,436
4/5/2023	David S. Tierney	Director	Sell	30,000	$16.83	$504,900.00	313,541
3/29/2023	Jeffrey Del Carmen	Insider	Sell	40,000	$16.70	$668,000.00	7,541
3/28/2023	Alicia Grande	CFO	Sell	58,216	$16.54	$962,892.64	50,557
3/22/2023	Alicia Grande	CFO	Sell	41,784	$16.50	$689,436.00	50,557
3/20/2023	Brian Elsbernd	Insider	Sell	50,000	$16.07	$803,500.00	138,076
12/6/2022	Gary Ingenito	Insider	Sell	5,918	$16.85	$99,718.30	30,802
11/23/2022	Philip H. Coelho	Director	Sell	9,999	$17.45	$174,482.55	149,553
11/23/2022	Steve Miller	COO	Sell	20,000	$17.34	$346,800.00	553,791
11/22/2022	Alicia Grande	CFO	Sell	120,000	$16.53	$1,983,600.00	27,442
11/21/2022	Patrick J. McEnany	CEO	Sell	150,000	$15.33	$2,299,500.00	3,902,606
11/21/2022	Philip H. Coelho	Director	Sell	70,000	$15.23	$1,066,100.00	179,553
11/21/2022	Steve Miller	COO	Sell	80,000	$15.28	$1,222,400.00	573,791
11/18/2022	Patrick J. McEnany	CEO	Sell	350,000	$15.62	$5,467,000.00	3,902,606
11/15/2022	Alicia Grande	CFO	Sell	60,000	$15.77	$946,200.00	147,442
11/11/2022	Donald A. Denkhaus	Director	Sell	20,000	$16.59	$331,800.00	277,666
11/11/2022	Preethi Sundaram	insider	Sell	56,786	$16.38	$930,154.68
9/23/2022	Alicia Grande	CFO	Sell	60,000	$11.90	$714,000.00	207,442
9/16/2022	Alicia Grande	CFO	Sell	90,000	$13.50	$1,215,000.00	267,442
9/15/2022	Preethi Sundaram	insider	Sell	18,214	$14.49	$263,920.86	22,053
9/14/2022	Alicia Grande	CFO	Sell	50,000	$15.57	$778,500.00	357,442
9/14/2022	Donald A. Denkhaus	Director	Sell	20,000	$15.34	$306,800.00	297,666
9/13/2022	Patrick J. McEnany	CEO	Sell	80,765	$15.33	$1,238,127.45	4,849,452
9/13/2022	Steve Miller	COO	Sell	107,933	$16.90	$1,824,067.70	653,791
8/29/2022	Alicia Grande	CFO	Sell	57,000	$14.20	$809,400.00	407,442
8/26/2022	Alicia Grande	CFO	Sell	11,095	$14.40	$159,768.00	464,442
8/22/2022	David S. Tierney	Director	Sell	20,000	$14.16	$283,200.00	308,207
8/18/2022	Steve Miller	COO	Sell	150,000	$13.53	$2,029,500.00	761,724
8/17/2022	Alicia Grande	CFO	Sell	130,741	$13.86	$1,812,070.26	475,537
6/22/2022	Gary Ingenito	Insider	Sell	6,152	$6.61	$40,664.72	22,053

See Full Table

SEC Filings (Institutional Ownership Changes) for Catalyst Pharmaceuticals (NASDAQ:CPRX)

79.22% of Catalyst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Catalyst Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/14/2025	Virtus Advisers LLC	22,804	$0.55M	0.7%	N/A	0.019%
5/14/2025	Freedom Investment Management Inc.	10,604	$0.26M	0.0%	-16.6%	0.009%
5/14/2025	MetLife Investment Management LLC	724,091	$17.56M	0.1%	+963.5%	0.594%
5/14/2025	Campbell & CO Investment Adviser LLC	95,079	$2.31M	0.2%	N/A	0.078%
5/14/2025	Oliver Luxxe Assets LLC	70,305	$1.71M	0.3%	+106.6%	0.058%
5/14/2025	Systematic Financial Management LP	181,390	$4.40M	0.1%	N/A	0.149%
5/14/2025	Resolute Capital Asset Partners LLC	129,356	$3.14M	1.8%	-5.9%	0.106%
5/14/2025	AlphaQuest LLC	8,589	$0.21M	0.0%	-80.4%	0.007%
5/14/2025	Advantage Alpha Capital Partners LP	20,037	$0.49M	0.1%	+53.5%	0.016%
5/14/2025	Martingale Asset Management L P	112,317	$2.72M	0.1%	+1.2%	0.092%
5/14/2025	Capital Fund Management S.A.	72,334	$1.75M	0.0%	-41.4%	0.059%
5/14/2025	EntryPoint Capital LLC	12,115	$0.29M	0.1%	N/A	0.010%
5/14/2025	BI Asset Management Fondsmaeglerselskab A S	14,248	$0.35M	0.0%	-87.8%	0.012%
5/14/2025	Hsbc Holdings PLC	34,963	$0.84M	0.0%	-3.8%	0.029%
5/14/2025	Quantbot Technologies LP	16,679	$0.40M	0.0%	+48.4%	0.014%
5/14/2025	Wellington Management Group LLP	48,447	$1.18M	0.0%	-6.0%	0.040%
5/13/2025	Northern Trust Corp	1,486,198	$36.04M	0.0%	-1.2%	1.219%
5/13/2025	Algert Global LLC	48,390	$1.17M	0.0%	+1.0%	0.040%
5/13/2025	Raymond James Financial Inc.	440,523	$10.68M	0.0%	+33.5%	0.361%
5/13/2025	Cresset Asset Management LLC	12,705	$0.31M	0.0%	N/A	0.010%
5/13/2025	Wealthedge Investment Advisors LLC	12,172	$0.30M	0.1%	N/A	0.010%
5/13/2025	American Century Companies Inc.	526,569	$12.77M	0.0%	+234.5%	0.432%
5/13/2025	Aberdeen Group plc	765,294	$18.56M	0.0%	+57.9%	0.628%
5/13/2025	Fox Run Management L.L.C.	57,118	$1.39M	0.2%	+50.4%	0.047%
5/13/2025	Boston Partners	1,275,325	$30.63M	0.0%	-1.3%	1.046%
5/13/2025	E Fund Management Co. Ltd.	9,785	$0.24M	0.0%	N/A	0.008%
5/13/2025	Russell Investments Group Ltd.	141,753	$3.44M	0.0%	-19.6%	0.116%
5/13/2025	Informed Momentum Co LLC	138,698	$3.36M	0.6%	+3.4%	0.114%
5/13/2025	HighTower Advisors LLC	81,340	$1.97M	0.0%	N/A	0.067%
5/12/2025	Knott David M Jr	212,000	$5.14M	2.4%	+1.0%	0.174%
5/12/2025	Public Sector Pension Investment Board	410,762	$9.96M	0.0%	+47.0%	0.337%
5/12/2025	Nuveen LLC	768,012	$17.19M	0.0%	N/A	0.630%
5/12/2025	Invesco Ltd.	1,199,627	$29.09M	0.0%	+41.7%	0.984%
5/12/2025	Sierra Summit Advisors LLC	26,478	$0.64M	0.1%	N/A	0.022%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	161,272	$3.91M	0.0%	N/A	0.132%
5/12/2025	Cynosure Group LLC	15,369	$0.37M	0.1%	+9.4%	0.013%
5/12/2025	Swiss National Bank	207,900	$5.04M	0.0%	-1.0%	0.170%
5/12/2025	Maryland State Retirement & Pension System	32,706	$0.79M	0.0%	-13.2%	0.027%
5/9/2025	Mutual of America Capital Management LLC	16,327	$0.40M	0.0%	-3.9%	0.013%
5/9/2025	Headlands Technologies LLC	7,737	$0.19M	0.0%	N/A	0.006%
5/9/2025	Deutsche Bank AG	186,801	$4.53M	0.0%	-6.8%	0.153%
5/9/2025	Charles Schwab Investment Management Inc.	1,326,771	$32.17M	0.0%	+6.4%	1.088%
5/9/2025	Vanguard Group Inc.	8,495,580	$206.02M	0.0%	+0.8%	6.966%
5/9/2025	Three Seasons Wealth LLC	20,324	$0.49M	0.2%	N/A	0.017%
5/9/2025	Atria Wealth Solutions Inc.	8,882	$0.22M	0.0%	N/A	0.007%
5/9/2025	PNC Financial Services Group Inc.	5,501	$0.13M	0.0%	+57.2%	0.005%
5/9/2025	Jupiter Asset Management Ltd.	488,587	$11.85M	0.1%	+1.4%	0.401%
5/9/2025	LSV Asset Management	703,802	$17.07M	0.0%	-9.4%	0.577%
5/8/2025	US Bancorp DE	7,328	$0.18M	0.0%	+17.8%	0.006%
5/8/2025	Natixis Advisors LLC	62,990	$1.53M	0.0%	+6.3%	0.052%
5/8/2025	Clark Estates Inc. NY	134,418	$3.26M	0.7%	-27.6%	0.110%
5/8/2025	Vestcor Inc	28,705	$0.70M	0.0%	+3.0%	0.024%
5/8/2025	XTX Topco Ltd	11,623	$0.28M	0.0%	-56.6%	0.010%
5/8/2025	GSA Capital Partners LLP	22,584	$0.55M	0.0%	-64.1%	0.019%
5/8/2025	Federated Hermes Inc.	74,484	$1.81M	0.0%	-57.3%	0.061%
5/7/2025	Meeder Asset Management Inc.	9,441	$0.23M	0.0%	-20.2%	0.008%
5/7/2025	Mackenzie Financial Corp	40,288	$0.98M	0.0%	+16.7%	0.033%
5/7/2025	Sheaff Brock Investment Advisors LLC	20,405	$0.50M	0.0%	N/A	0.017%
5/7/2025	Bryce Point Capital LLC	20,608	$0.51M	0.4%	-62.1%	0.017%
5/7/2025	LPL Financial LLC	74,229	$1.80M	0.0%	+28.0%	0.061%
5/7/2025	Zurcher Kantonalbank Zurich Cantonalbank	31,897	$0.77M	0.0%	+11.3%	0.026%
5/7/2025	Skandinaviska Enskilda Banken AB publ	786,900	$19.08M	0.1%	+7.5%	0.645%
5/6/2025	Pacer Advisors Inc.	854,367	$20.72M	0.0%	-71.1%	0.701%
5/6/2025	Assetmark Inc.	83,236	$2.02M	0.0%	+17.6%	0.068%
5/6/2025	Navellier & Associates Inc.	12,524	$0.30M	0.0%	-11.6%	0.010%
5/6/2025	Cetera Investment Advisers	58,180	$1.41M	0.0%	+34.9%	0.048%
5/6/2025	Royce & Associates LP	1,598,360	$38.76M	0.4%	-14.3%	1.311%
5/6/2025	Legato Capital Management LLC	53,652	$1.30M	0.2%	N/A	0.044%
5/6/2025	Universal Beteiligungs und Servicegesellschaft mbH	170,836	$4.14M	0.0%	-4.5%	0.140%
5/5/2025	Horizon Investment Services LLC	49,995	$1.21M	0.6%	+26.5%	0.041%
5/5/2025	Allianz Asset Management GmbH	694,125	$16.83M	0.0%	+397.8%	0.569%
5/5/2025	Gallacher Capital Management LLC	16,223	$0.39M	0.2%	N/A	0.013%
5/5/2025	Los Angeles Capital Management LLC	188,316	$4.57M	0.0%	-7.7%	0.154%
5/5/2025	Hussman Strategic Advisors Inc.	84,000	$2.04M	0.5%	-20.0%	0.069%
5/5/2025	Jackson Creek Investment Advisors LLC	29,284	$0.71M	0.2%	-59.2%	0.024%
5/2/2025	Segall Bryant & Hamill LLC	91,936	$2.23M	0.0%	+14.4%	0.075%
5/2/2025	Victory Capital Management Inc.	539,782	$13.09M	0.0%	+82.3%	0.443%
5/2/2025	Massachusetts Financial Services Co. MA	73,810	$1.79M	0.0%	-2.2%	0.061%
5/2/2025	Castlekeep Investment Advisors LLC	84,095	$2.04M	1.0%	-1.1%	0.069%
5/2/2025	Lokken Investment Group LLC	14,299	$0.35M	0.1%	N/A	0.012%
5/2/2025	Hohimer Wealth Management LLC	18,070	$0.44M	0.1%	+3.6%	0.015%
5/2/2025	Sigma Planning Corp	21,275	$0.52M	0.0%	N/A	0.017%
5/1/2025	CWM LLC	13,411	$0.33M	0.0%	+21.8%	0.011%
5/1/2025	Louisiana State Employees Retirement System	52,800	$1.28M	0.0%	-2.6%	0.043%
5/1/2025	New York State Common Retirement Fund	92,001	$2.23M	0.0%	+155.3%	0.075%
5/1/2025	Mutual of America Capital Management LLC	16,327	$0.40M	0.0%	-3.9%	0.013%
4/30/2025	Cerity Partners LLC	28,841	$0.70M	0.0%	+8.9%	0.024%
4/30/2025	Alps Advisors Inc.	16,476	$0.40M	0.0%	-3.7%	0.014%
4/30/2025	Banque Pictet & Cie SA	23,121	$0.56M	0.0%	N/A	0.019%
4/30/2025	Linden Thomas Advisory Services LLC	35,233	$0.85M	0.1%	+7.9%	0.029%
4/30/2025	DekaBank Deutsche Girozentrale	171,376	$4.15M	0.0%	-6.5%	0.141%
4/30/2025	Stratos Wealth Advisors LLC	83,475	$2.02M	0.1%	N/A	0.068%
4/29/2025	Envestnet Asset Management Inc.	78,195	$1.90M	0.0%	+21.4%	0.064%
4/29/2025	Penserra Capital Management LLC	90,552	$2.20M	0.0%	N/A	0.074%
4/29/2025	Bank of New York Mellon Corp	709,925	$17.22M	0.0%	-1.9%	0.582%
4/29/2025	Moody Aldrich Partners LLC	182,571	$4.43M	0.9%	-15.3%	0.150%
4/28/2025	Principal Financial Group Inc.	617,506	$14.98M	0.0%	+2.8%	0.506%
4/28/2025	Oregon Public Employees Retirement Fund	25,639	$0.62M	0.0%	-2.7%	0.021%
4/28/2025	Meritage Portfolio Management	48,039	$1.17M	0.1%	+4.2%	0.039%
4/28/2025	Teacher Retirement System of Texas	28,889	$0.70M	0.0%	-8.7%	0.024%

Data available starting January 2016

See Full Table

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.

Today's Range

Now: $23.40

$23.28

$24.07

50 Day Range

MA: $23.07

$20.67

$25.74

52 Week Range

Now: $23.40

$14.75

$26.16

Volume

1,177,607 shs

Average Volume

1,109,447 shs

Market Capitalization

$2.85 billion

P/E Ratio

19.83

Dividend Yield

N/A

Beta

0.7

Who are the company insiders with the largest holdings of Catalyst Pharmaceuticals?: Catalyst Pharmaceuticals' top insider shareholders include:
Patrick J Mcenany (CEO)
Steve Miller (Insider)
David S Tierney (Director)
Richard J Daly (CEO)
Brian Elsbernd (Insider)
Gary Ingenito (Insider)
Alicia Grande (CFO)
Carmen Jeffrey Del (Insider)
Molly Harper (Director)
Learn More about top insider investors at Catalyst Pharmaceuticals.
Who are the major institutional investors of Catalyst Pharmaceuticals?: Catalyst Pharmaceuticals' top institutional shareholders include:
Vanguard Group Inc. — 6.97%
Royce & Associates LP — 1.31%
Northern Trust Corp — 1.22%
Charles Schwab Investment Management Inc. — 1.09%
Boston Partners — 1.05%
Invesco Ltd. — 0.98%
Learn More about top institutional investors of Catalyst Pharmaceuticals stock.
Which major investors are selling Catalyst Pharmaceuticals stock?: During the last quarter, CPRX stock was sold by these institutional investors:
Pacer Advisors Inc.
Royce & Associates LP
Allspring Global Investments Holdings LLC
BI Asset Management Fondsmaeglerselskab A S
Federated Hermes Inc.
LSV Asset Management
Clark Estates Inc. NY
Capital Fund Management S.A.
Within the previous year, company insiders that have sold Catalyst Pharmaceuticals company stock include:
Patrick J Mcenany (CEO)
Steve Miller (Insider)
David S Tierney (Director)
Richard J Daly (CEO)
Brian Elsbernd (Insider)
Gary Ingenito (Insider)
Alicia Grande (CFO)
Learn More investors selling Catalyst Pharmaceuticals stock.
Which major investors are buying Catalyst Pharmaceuticals stock?: In the last quarter, CPRX stock was acquired by institutional investors including:
Nuveen LLC
MetLife Investment Management LLC
Allianz Asset Management GmbH
American Century Companies Inc.
Invesco Ltd.
Aberdeen Group plc
Victory Capital Management Inc.
Systematic Financial Management LP